University of Utah Annual IRB Member Training Ann Johnson, PhD Associate Director Institutional Review Board
|
|
- Gwenda Anderson
- 6 years ago
- Views:
Transcription
1 University of Utah Annual IRB Member Training 2016 Ann Johnson, PhD Associate Director Institutional Review Board
2 Overview of NIH policy on the use of a Single IRB for multi site research (and other federal thoughts) Overview of sirb premise and process Overview of the NCATS TIC grant and what that means for Utah Plans moving forward
3 Final NIH Policy on the Use of a Single Institutional Review Board for Multi Site Research available online Requires the use of a single IRB for multi site research funded by the NIH Applies to all competing grant applications received on or after May 25, 2017
4 The goal of this policy is to enhance and streamline the IRB review process in the context of multi site research so that research can proceed as effectively and expeditiously as possible. Eliminating duplicative IRB review is expected to reduce unnecessary administrative burdens and systemic inefficiencies without diminishing human subjects protections. The shift in workload away from conducting redundant reviews is also expected to allow IRBs to concentrate more time and attention on the review of single site protocols, thereby enhancing research oversight.
5 Ancillary Reviews Qualifications & Training Compliance & Oversight Human Research Protection Program Conflict of Interest IRB HIPAA Privacy Board
6 Reliance agreement execution Outline the roles and responsibilities between the sirb and the local site Attempts to standardize and streamline Initial sirb review + local review Bringing review times to the mean Ongoing review and monitoring by sirb and locally Continuing reviews, amendments, report forms, auditing
7 Investigator and study team Human Research Protection Program (HRPP) Local IRB Local Conflict of Interest Review Local ancillary committees Local training and compliance
8 How do I interact with the CIRB? What is the communication plan? What does the CIRB expect of me? What requirements does my institution have that are not covered by CIRB review? How do I continue to meet those requirements? Do policies of the CIRB differ from policies of my local IRB and institution? How do I adhere to both sets of policies?
9 What are the terms and conditions of the Reliance Agreement with the CIRB? What are our responsibilities as the local HRPP? What local context concerns, state laws, institutional policies apply to this protocol? How do we communicate this to the CIRB? How do we confirm these local requirements are met? How do ancillary committee reviews get completed our institution? How do we track this protocol as a research project happening at our institution? How do we handle problems that occur at our research site?
10 1. Investigator submits the protocol and associated documents for facilitated review at the local site. Is this a single application to a coordinating body, or separate applications to different groups and committees? 2. All applicable groups/committees review the protocol and documents. A coordinating body for facilitated review? Perhaps. Conflict of interest review Legal review Scientific review Funding and billing review Resources review Etc.
11 3. Groups/Committees provide feedback on the protocol and documents. This may include revisions that need to be made locally or to the overall study 4. Investigators address local feedback and revisions. 5. Feedback and revisions for the overall study are sent to the CIRB. Does the coordinating body do this, or the investigator?
12 There is likely to be an overall consent (and authorization) document for the study. The local site should be able to add local language to key sections. Person to Contact Research Related Injury Statement HIPAA Authorization Others, depending on state law and local policies The investigator should fill this in as part of the initial facilitated review. The local groups/committees should verify it is correct and meets requirements.
13 1. CIRB reviews the overall study and makes appropriate determinations. 2. CIRB reviews the local requirements, feedback, and revisions, ensuring these are addressed and incorporated. 3. CIRB issues approval of the study and of participation of the local site. The CIRB may do all of this as part of an initial review of the study OR may consider the local site as part of an amendment.
14 1. The investigator provides CIRB approval documentation and the final version of the approved documents to the local groups/committees. 2. The groups/committees verify the approval and send a facilitated review acknowledgement. 3. The investigator may begin the research at the local site.
15 Local IRB review may still be required for certain determinations; refer to the terms and conditions of the Reliance Agreement. Local amendments HIPAA determinations Consent documents Shared IRB Reviews would likely have a different process to facilitate the review
16 Gathering all necessary information efficiently Using all necessary information meaningfully Multiple electronic systems Communication barriers Standardizing key policies and processes Collecting reliable and valid metrics Improving review times
17 Funded by the National Center for Advancing Translational Sciences Works in collaboration with the national CTSAs Goal to accelerate the translation of novel interventions to evidence based treatment
18 Three awards: University of Utah Johns Hopkins & Tufts collaboration Vanderbilt & Duke collaboration The three centers will work together to develop processes for sirb model Master contracts Streamline protocol design and procedures Patient engagement
19 Review same components, but for multiple sites Collect local context and review documentation for use by the staff and convened board Provide sirb specific documentation to local sites Open up ERICA to outside users
20 Need for local SOPs on how to defer to a CIRB and complete local facilitated review requirements. Need to consider how CIRB review interplays with local electronic systems and submission processes. Need to have a plan for training and informing research teams and HRPP officers on how to complete local processes for facilitated review. Need to have a plan for ensuring research teams understand differences between CIRB policy and local policy. Need for local SOPs for monitoring compliance at the local site.
21 Update ERICA to allow for better indication of sirb use Electronically track reliance agreements and connect that system to ERICA Educate the research community! Develop guidance and instruction documents Work with TIN partners and other academic institutions to develop best practices and standardizations Engage with multiple institutions to become a more prolific sirb Measure metrics
22 Question & Comments? Thank you!
External IRB Review What Does it Mean for Your Institution
External IRB Review What Does it Mean for Your Institution Wesley G Byerly, Pharm.D. Associate Vice President for Research Integrity and Regulatory Affairs University of Connecticut and UCONN Health HCCA
More informationEthics Committees/IRBs Today: Challenges for Efficiency and Quality
Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients
More informationRESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH
1. Overview RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH The ethical and regulatory requirements of The Ohio State University Human Research Protection Program (HRPP) apply to all research
More informationQuality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework
1 Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework Mandy Morneault Research Compliance Monitor University of Washington Institute of Translational Health
More informationCTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK
CTSA Trial Innovation Network Early Vision & Goals MONICA SHAH, MD DIRECTOR, TRIAL INNOVATION NETWORK What Do They Have in Common? Hammer M. Harvard Business Review, 2004. What Do They Have in Common?
More informationWebinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation.
Webinar Tips Please mute your phone. Please do not put the call on hold. There will be time for questions after the presentation. Carolinas Collaborative Pilot RFA Webinar May 8, 2017 Partners Overview
More information2018 Common Rule Implementation Checklist
2018 Common Rule Implementation Checklist High Priority Action Items The following table outlines certain actions institutions should consider taking ahead of the 2018 Common Rule s effective and general
More informationExpanded Access and the Individual Patient IND
Expanded Access and the Individual Patient IND Research Wednesdays April 26, 2017 Erika Segear Johnson, PhD, RAC Associate Director of Regulatory Affairs Office of Regulatory Affairs and Quality Office
More informationDoing Human Subjects Research? Changing NIH Policies May Impact You
Doing Human Subjects Research? Changing NIH Policies May Impact You Reforms & Initiatives To enhance the stewardship of research involving human subjects, NIH is implementing the following: All Research
More informationSOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS
SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS Catherine Jahrsdorfer, R.N., B.S.N. Director of Clinical Services Office of Clinical Research January 2 & 3, 2012 Learning
More informationBasics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS
Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Presentation Outline What is human subjects research? What are the reasons for IRB review? What is exempt from
More informationChristopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013
Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Basic Laboratory Research Clinical Research Improved Public Health Translational Research Population Research Basic
More informationJune 7, Harold E. Varmus, MD Director National Cancer Institute 31 Center Drive Building 31 Room 11A48 MSC 2590 Bethesda, Maryland
Harold E. Varmus, MD Director National Cancer Institute 31 Center Drive Building 31 Room 11A48 MSC 2590 Bethesda, Maryland 20892-2590 Dear Harold: Thank you, again, for taking the time to come to ASCO
More informationStreamlining IRB Procedures for Expanded Access
Streamlining IRB Procedures for Expanded Access Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation Richard Klein Director, FDA Patient Liaison Program Office of Health and Constituent Affairs
More informationOffice for Human Subject Protection. University of Rochester
POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,
More informationTOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH
Investigators Responsibility #1: Design and Implement Ethical Research Consistent with the Three Ethical Principles Delineated in The Belmont Report. The Belmont Report: Three Basic Ethical Principles:
More informationAdvancing the Use of Central IRBs for Multicenter Clinical Trials
Advancing the Use of Central IRBs for Multicenter Clinical Trials Cynthia Hahn, Chief Operating Officer, The Feinstein Institute for Medical Research July 10, 2015 CTTI Mission To identify and promote
More informationRules of Human Experimentation
Rules of Human Experimentation Elaine Larson CUMC IRB Chair Associate Dean for Research, School of Nursing Professor of Epidemiology, Mailman School of Public Health Oversight for Human Research Office
More informationPOLICY AND PROCEDURES ON SURVEY ADMINISTRATION UNC ESHELMAN SCHOOL OF PHARMACY
POLICY AND PROCEDURES ON SURVEY ADMINISTRATION UNC ESHELMAN SCHOOL OF PHARMACY THE IMPORTANCE OF SURVEYS Approved, December 20, 2012 A survey is a systematic method of collecting data from a population
More informationHuman Research Protection Program Guidance for Human Research Determination
Human Research Protection Program Guidance for Human Research Determination I.1.A The sole purpose of the Institutional Review Board (IRB), as defined in federal statutes, is the protection of human subjects
More informationSummary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015
Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the
More informationThe Clinical Research Regulatory Process
The Clinical Research Regulatory Process Understanding the Impact A CenterWatch-Complion Survey by Rick Arlow, Founder and CEO Complion Inc. Introduction The importance of data validity obtained from a
More informationEthical, Political and Social Issues in Joint Ethics Review: Lessons from the Indiana University/Moi University Academic Research Ethics Partnership
Ethical, Political and Social Issues in Joint Ethics Review: Lessons from the Indiana University/Moi University Academic Research Ethics Partnership Eric M. Meslin, Ph.D. Director, Indiana University Center
More informationWHAT IS OUR RESEARCH PORTFOLIO?
Clinical Research Management System Online Collaborative Research Environment (OnCore) Forte Research Systems Christian Stephens Office of Research Informatics Project Manager Mike Neuenfeldt Forte Project
More informationThe EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria Question 1: What laws or regulations apply to an application for conducting a clinical
More informationHRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies
Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates
More informationThe Research Services Organization (RSO) of the Academic Health Center
Annual Report 2005 The Research Services Organization (RSO) of the Academic Health Center A Summary of the Eighth Year of Operations Submitted by: Mark S. Paller, M.D., M.S. Director, Research Services
More information1 The Clinical Research Coordinator (CRC)... 1
TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...
More informationParticipant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way.
Name and Clinic Number IRB # 08-007049 00 Consent form approved July 16, 2015; This consent valid through July 15, 2016; 1. General Information About This Research Study Study Title: Mayo Clinic Biobank
More informationSITE SUBMISSION FORM (SINGLE SITE)
*We accept study submissions by email, fax or mail. 1. STUDY INFORMATION A. Sponsor: Protocol.: Study Title: B. Study Type: Drug, Biologic or Dietary Supplement (please complete section C., then proceed
More informationTier Assessment/Setting - Quick Guide to Competency Levels
Tier Assessment/Setting - Quick Guide to Competency Levels RESEARCH OPERATIONS Competency Fundamental Skilled Advanced Interactions with IRB Candidate has used the system to successfully submit documents
More informationTrends in Oversight of Human Research Protections?
Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for
More informationProtection of Research Participants: The IRB Process and the Winds of Change
Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick
More informationRECRUITING OF AND ADVERTISING FOR SUBJECTS
1. POLICY Steering Committee approved 9/19/11 The informed consent process begins when a potential human research subject first learns of a study, which is usually accomplished through recruitment efforts.
More informationRecruitment of Subjects Best Practices
UCLA CTSI WELCOME TO ONLINE TRAINING FOR CLINICAL RESEARCH COORDINATORS ROLE OF THE RESEARCH COORDINATOR Recruitment of Subjects Best Practices May 2016 Objectives Definitions Goals and Barriers Recruitment
More informationStandard Operating Procedures (SOPs)
Organizational Strategies for Clinical Trials Standard Operating Procedures (SOPs) SUSAN JACKSON, MPA UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE UNC CENTER
More informationClinical Research at MSU
Financial Administration Development Program: Clinical Research at MSU Kristen Burt, Office of Regulatory Affairs (ORA) Sharon Schooley, Clinical & Translational Sciences Institute (CTSI) February 24,
More informationEmbryonic Stem Cell Research Oversight Committee (ESCRO) Application Form
Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form A. Demographic Information Date of Submission: Reason for Submission: New Project Response to Comments Reconsideration Disapproval
More informationGovernance Policies for PCORnet, the National Patient-Centered Clinical Research Network
Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network 1.0 Leadership and Decision-Making When reading this document it is important to note that there are several categories
More informationR&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:
Research as a Participating site STANDARD OPERATING PROCEDURE FOR OVERSIGHT SOP No: P08/PF2 V2 Effective Date: 31 st July 2013 Supersedes: P08/PF2 Revision Date: 31 st March 2014 Author: Position: Approved
More informationQuality Assurance in Clinical Trials
Quality Assurance in Clinical Trials Doctor Catherine CORNU, Lyon clinical Investigation Centre EUDIPHARM December 5th, 2011 1 Introduction: quality in clinical research in human subjects Regulatory requirements:
More informationCANCER CENTER SCIENTIFIC REVIEW COMMITTEE
CANCER CENTER SCIENTIFIC REVIEW COMMITTEE The Clinical Scientific Review Committee (SRC) at The Medical College of Wisconsin Cancer Center plays a vital role in protocol review and monitoring to ensure
More informationCreating, Managing and Delivering Regulated Content in Pharma. Jim Nichols VP, US Operations & Life Sciences DitaExchange Inc.
Creating, Managing and Delivering Regulated Content in Pharma Jim Nichols VP, US Operations & Life Sciences DitaExchange Inc. DitaExchange simplifies the way organizations Create Manage Deliver Re-use
More informationHuman Subjects Protection: Training for Research Teams
Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center
More informationDr. David D. Lee, Provost and VP for Academic Affairs
POLICY & PROCEDURE DOCUMENT NUMBER: 2.7000 SECTION: TITLE: Research Institutional Biosafety Committee Policy DATE: November 6, 2017 Authorized by: Dr. David D. Lee, Provost and VP for Academic Affairs
More informationAudit Committee Presentation FY2011 Audit Plan (annual risk assessment) August 16, 2010
Audit Committee Presentation FY2011 Audit Plan (annual risk assessment) August 16, 2010 INTERNAL AUDITS ACADEMIC ENTERPRISE Are research and development expenses expended in accordance with the terms of
More informationAssistant Business Manager Job Description
Assistant Business Manager Job Description Responsible to: Responsible for: Business Manager Admin Team made up of: Attendance and Admission Officer Admin Assistant x2 Business Administration Apprentice
More informationTMF Reference Model. Topline results of 2014 TMF Survey #4. August 2014 Fran Ross TMF Survey Sub-team
TMF Reference Model Topline results of 2014 TMF Survey #4 August 2014 Fran Ross TMF Survey Sub-team Trial Master File (TMF) Survey Background TMF Survey purpose: industry-wide, gather insight into quality,
More informationRelated Donor Informed Consent to Participate in Research
Related Donor Informed Consent to Participate in Research This is an informed consent document for a research study that your family member is participating in. This document will inform you about the
More informationApril 13, Background
Pfizer Inc 235 East 42nd Street New York, NY 10017-5755 Tel 212 733 4210 Fax 646 383 9249 Email: marc.wilenzick@pfizer.com April 13, 2009 http://www.regulations.gov Christine Ireland Committee management
More informationNew NIH Clinical Trial Requirements for Grants & Contracts 2017/2018
New NIH Clinical Trial Requirements for Grants & Contracts 2017/2018 Changes in Human Subjects Research Grant Application Process Clinical Trial Applications IRB Single IRB Certificates of Confidentiality
More informationContents. Connected Competence Q&A June 2017
Connected Competence Q&A June 2017 Contents Introduction to Connected Competence... 2 What is Connected Competence?... 2 How does it work?... 2 Which organisations have adopted Connected Competence?...
More informationNIH Clinical Trials Updates: Putting it All Together. Why the changes to NIH-funded studies involving human subjects?
NIH Clinical Trials Updates: Putting it All Together Sherry Mills, MD MPH Director Office of Extramural Programs Office of Extramural Research NIH 1 Why the changes to NIH-funded studies involving human
More informationCTTI Overview One Decade of Impact. One Vision Ahead.
Feb. 6, 2018 CTTI Overview One Decade of Impact. One Vision Ahead. Pamela Tenaerts, MD, MBA Executive Director #CelebrateCTTI Discover how CTTI has influenced the clinical trials enterprise during the
More informationRole of the IRB in Human Subjects Research
Role of the IRB in Human Subjects Research Richard D. Stevenson, M.D. Chair Institutional Review Board for Health Sciences Research (IRB-HSR) University of Virginia Office of the Vice President for Research
More informationRare Diseases: Challenges and Opportunities NIH Perspective
Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes
More informationNIH funded Human Subjects Research/Clinical Trials and the Transition to Forms E. How Do Changing NIH Policies Impact Me?
NIH funded Human Subjects Research/Clinical Trials and the Transition to Forms E How Do Changing NIH Policies Impact Me? LCOM Informational Sessions Nov. 14, 16 2017 Jeralyn Haraldsen, PhD Grant Proposal
More informationMODULE I: MEDICARE & MEDICAID GENERAL COMPLIANCE TRAINING
MODULE I: MEDICARE & MEDICAID GENERAL COMPLIANCE TRAINING 2 0 1 4 A Message From Our CEO and Compliance Officer At PacificSource, we pride ourselves on maintaining a culture of compliance and high ethical
More informationGW Policy on Human Research Protection Program
GW Policy on Human Research Protection Program 1. PURPOSE 1.1. This policy establishes the [Organization] s Human Research Protection Program (HRPP) and its commitment to protect the rights and welfare
More informationResearcher Data Security Self- Assessment Questionnaire for Existing Studies
Researcher Data Security Self- Assessment Questionnaire for Existing Studies Version 1.0 October 2016 Researcher Data Security Program Self- Assessment Questionnaire for Existing Studies Purpose The Harvard
More informationThe University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit. Internal Audit Report 14:07
Office of Internal Audit The University of Texas Southwestern Medical Center Institutional Review Board Oversight Audit Internal Audit Report 14:07 November 17, 2014 Table of Contents I. Executive Summary
More informationTrial oversight SOP for HEY-sponsored CTIMPs
R&D Department Trial oversight SOP for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored in a retrieval system
More informationTHE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION
THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices
More informationOracle. Talent Management Cloud Using Talent Review and Succession Management. Release 12. This guide also applies to on-premises implementations
Oracle Talent Management Cloud Using Talent Review and Succession Management Release 12 This guide also applies to on-premises implementations Oracle Talent Management Cloud Part Number E73312-04 Copyright
More informationNIH Policy on the Dissemination of NIH-Funded Clinical Trial Information
This document is scheduled to be published in the Federal Register on 09/21/2016 and available online at https://federalregister.gov/d/2016-22379, and on FDsys.gov [BILLING CODE 4140-01-P] DEPARTMENT OF
More informationWhat is an IRB (Institutional Review Board)?
What is an IRB (Institutional Review Board)? The Belmont Report The Belmont Report on the Ethical Principles and Guidelines for the Protection of Human Subjects of Research was prepared by the National
More informationLearn More: Protecting Human Subjects Participating in Research and their Personal Privacy + NIH Clinical Trial & Common Rule Updates
RESEARCH ADMINISTRATION November 2017 Northeastern University Learn More: Protecting Human Subjects Participating in Research and their Personal Privacy + NIH Clinical Trial & Common Rule Updates Learning
More informationData Governance Implementation
Service Offering Implementation Leveraging Data to Transform the Enterprise Benefits Use existing data to enable new business initiatives Reduce costs of maintaining data by increasing compliance, quality
More informationNot My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center
Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center Office of Research Compliance and Quality Assurance Yolanda P. Davis Sr. Research Compliance Officer Author: Yolanda P.
More informationResearch Job Summaries
Job Summaries Job 32713 32712 32711 32613 32612 32611 32516 32515 32514 32513 32512 32511 Chief Officer Deputy Chief Officer Senior Officer Officer The Chief Officer (CRO) serves as an integral member
More informationSAMPLE Marketing Slides for Building a Compliance Program
SAMPLE Marketing Slides for Building a Compliance Program Compliance Mission A central organization that integrates compliance programs and provides oversight to existing programs to provide a reasonable
More informationHospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)
Page 1 of 8 Hospital Authority (HA) Guide on Research Ethics (for Study Site & Version Effective Date 2 01/02/2015 Document Number HAHO-CE&TM-HA REC Author HA Head Office Steering Committee on Research
More informationAPPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1
APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD Revised January 2010 Page 1 The IRB Proposal Includes: 1. All documents, other than the informed consent form, should be understandable to an informed
More informationReport on recognising organisations as awarding bodies
Report on recognising organisations as awarding bodies The recognition process February 2008 QCA/08/3569 Contents The recognition process... 3 Background... 3 Current recognition process... 3 Reducing
More informationInvestigator Manual. Human Subjects Protection Program
Human Subjects Protection Program HRP-103, Revised June 1, 2015 HRP-103 06/01/2015 2 of 33 Table of Contents Scope... 3 What is the purpose of this manual?... 3 What is Human Research?... 3 What is the
More informationRegulatory Change Management
Regulatory Change Management Maturity Model: From Ad Hoc to Agile November 2015 Michael Rasmussen, J.D., GRCP, CCEP The GRC Pundit @ GRC 20/20 Research, LLC OCEG Fellow @ www.oceg.org Change is the Greatest
More informationHow Data Managers Support Prospective Research
How Data Managers Support Prospective Research CIBMTR Data Managers Meeting February 20, 2018 Hati Kobusingye & Deborah Mattila Prospective Clinical Research Agenda Background - Prospective Research (RCI
More information50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED?
50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? Kevin L. Nellis, MS, CIP Executive Director, Human Research Protections and Quality Assurance Kathleen E. Powderly, CNM, PhD Director, John Conley
More informationITSM Process/Change Management
ITSM Process/Change Management Process Documentation Revision Date: December 13, 2017 Version Number: 2.0 Document Ownership Document Owner Maury Collins Revision History ITSM Role, Department Service
More informationMONITORING AND REPORTING (ARTICLE
CBD Distr. LIMITED UNEP/CBD/NP/COP-MOP/1/L.10 16 October 2014 IGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY SERVING AS THE MEETING OF THE PARTIES TO THE NAGOYA PROTOCOL
More informationPARTNERS HUMAN RESEARCH COMMITTEE. Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review
PARTNERS HUMAN RESEARCH COMMITTEE Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review For the purposes of this Primer, tissue is defined as any biological specimen obtained
More informationProfessor Mervyn King Chairman International Integrated Reporting Council Submitted via
Professor Mervyn King Chairman International Integrated Reporting Council Submitted via www.theiirc.org/consultationdraft2013 15 July 2013 Dear Professor King, Consultation draft of the International
More informationESRC Research Ethics Framework - Frequently Asked Questions (FAQs)
ESRC Research Ethics Framework - Frequently Asked Questions (FAQs) The following FAQs reflect typical questions asked of the ESRC Research Ethics Framework (REF). Where appropriate, reference is made to
More informationHR/Payroll Shared Services Service Level Agreement. December 1, 2017
HR/Payroll Shared Services Service Level Agreement December 1, 2017 Table of Contents Purpose... 2 Future reviews and amendments to this Service Level Agreement... 2 Objectives of the Service... 2 Service
More informationEfficiency. Purpose of the Checklist. Description
Efficiency Purpose of the Checklist To guide and support public procurement practitioners in reviewing, developing and updating their procurement framework, according to the 12 principles of the Recommendation
More informationImplementation Life-cycle SOP
1.0 Commercial in Confidence 11-Aug-2006 1 of 12 Implementation Life-cycle SOP Document No: H4_SOP_0100 Prepared by: David Brown Date: 11-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 11-Aug-2006
More informationPatient Handbook on Stem Cell Therapies
Patient Handbook on Stem Cell Therapies WWW.ISSCR.ORG WWW.CLOSERLOOKATSTEMCELLS.ORG Patient Handbook on Stem Cell Therapies Introduction We have all heard about the extraordinary promise that stem cell
More informationThe long anticipated draft of the FDA s
This article provides an overview of the draft guidance, the key changes in relation to the 1987 guidance, and reviews its potential impact on the current industry approaches to science- and risk-based
More informationReview PROCESS, decision making PROCESS and communication BY
Review PROCESS, decision making PROCESS and communication BY ethics committee Dr. Reneega Gangadhar, Professor & Head Department of Pharmacology Govt. Medical college Trivandrum Outline Review process
More informationCanadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines
Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines 1. Introduction The Canadian Cancer Clinical Trials Network (3CTN) will support a portfolio of academic clinical trials
More informationMaking Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials
Cognizant 20-20 Insights Making Life Easier for Investigators: A Shared Solution for Smarter, Faster Clinical Trials The industry s Shared Investigator Platform significantly reduces the time and cost
More informationWCG ACADEMY COURSE OVERVIEW
WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations
More informationStanford University IRB Guidance On Data and Tissue Repositories
Stanford University IRB Guidance On Data and Tissue Repositories Databases, registries (data banks), and repositories (tissue banks) all involve the collection and storage of information and/or biological
More informationSPTF Universal Standards for. Social Performance. Management. Version 2.0, Published August 2016
SPTF Universal Standards for Social Performance Version 2.0, Published August 2016 Management Pathway to Improved Practice REPORT 5 1 LEARN Responsible Inclusive Finance 2 ASSESS IMPLEMENT 4 PLAN 3 The
More informationEthical Principles in Clinical Research
Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies
More informationExpanded Access (including Emergency Use & Humanitarian Use Devices)
Expanded Access (including Emergency Use & Humanitarian Use Devices) Bertha delanda, CIP IRB Training Specialist Research Compliance Office March 2012 What Is Expanded Access? Permits use of an investigational
More informationProduction Assistance for Cellular Therapies PACT
Production Assistance for Cellular Therapies PACT Traci Heath Mondoro, PhD NHLBI Bethesda, Maryland Renewed PACT Program Renewed January 15, 2010 Scope and size expanded Cell Processing Facilities (CPFs)
More informationExpanded Access. to Investigational Drugs & Biologics. for Treatment Use
SJMHS Research Compliance Office Guidance Document Expanded Access to Investigational Drugs & Biologics for Treatment Use May 2015 1 Expanded Access to Investigational Drugs & Biologics for Treatment Use
More information